Probiotic Lactobacillus Reuteri and Oral Microbiota
OMICI
Oral Microbiota Shift After 12-week Supplementation With Lactobacillus Reuteri DSM 17938 and PTA 5289
1 other identifier
interventional
44
0 countries
N/A
Brief Summary
In February 2013, 44 healthy adults was recruited and randomized to daily intake of lozenges with or without Lactobacillus reuteri strains DSM 17938 and PTA 5289 for 12 weeks. The effect of these Lactobacillus reuteri strains on the oral microbial composition was monitored before, after 4, 8 and 12 weeks and after 1 and 6 months after exposure was completed. For this purpose saliva and tooth plaque was collected. Of 44 included subjects, 41 completed the study. The used Lactobacillus reuteri containing lozenges are commercially available and identical placebo lozenges was obtained from the manufacturer. The study product was well tolerated with no observed side effects. Compliance was excellent. The investigators' primary outcome was to determine whether daily intake of Lactobacillus reuteri strains DSM 17938 and PTA 5289 for 12 weeks alters the tooth colonizing bacterial plaque composition determined by a multiplex sequencing technique. Effects are put in relation to general knowledge on bacterial profiles associated with risk to develop dental caries and periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Mar 2013
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 23, 2014
CompletedFirst Posted
Study publicly available on registry
December 8, 2014
CompletedDecember 8, 2014
November 1, 2014
5 months
November 23, 2014
December 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in oral bacteria biofilm composition after 12-week supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289
The change in bacteria colonizing the oral cavity after 12 weeks treatment with L. reuteri is analyzed
Baseline, after 4, 8 and 12 week treatment, and 1 and 6 months after treatment has terminated
Study Arms (2)
Test group with L. reuteri
ACTIVE COMPARATORSubjects in the test group take one Lactobacillus reuteri DSM 17938 and PTA 5289 containing lozenge in the morning and one in the evening.
Placebo group without L. reuteri
PLACEBO COMPARATORSubjects in the placebo group take one placebo lozenges with same look, taste and smell as the test lozenge but lacking the Lactobacillii the morning and one in the evening.
Interventions
Subjects in the test group are given one lozenges with Lactobacillus reuteri DSM 17938 and PTA 5289 in the morning and one in the evening
Placebo lozenges with no Lactobacillus reuteri DSM 17938 and PTA 5289
Eligibility Criteria
You may qualify if:
- Adult,
- healthy,
- no antibiotic treatment and no intake of probiotic products latest 3 months
You may not qualify if:
- Acute or chronic disease at recruitment, medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
Related Publications (1)
Romani Vestman N, Chen T, Lif Holgerson P, Ohman C, Johansson I. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. PLoS One. 2015 May 6;10(5):e0125812. doi: 10.1371/journal.pone.0125812. eCollection 2015.
PMID: 25946126DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ingegerd Johansson, Professor
Umea university, Sweden
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 23, 2014
First Posted
December 8, 2014
Study Start
March 1, 2013
Primary Completion
August 1, 2013
Study Completion
August 1, 2013
Last Updated
December 8, 2014
Record last verified: 2014-11